2012
DOI: 10.1002/hlca.201100366
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Anti‐HIV Activity of Triazolo‐Fused 3′,5′‐Cyclic Nucleoside Analogues Derived from an Intramolecular Huisgen 1,3‐Dipolar Cycloaddition

Abstract: Triazolo‐fused 3′,5′‐cyclic nucleoside analogues were synthesized by an intramolecular 1,3‐dipolar cycloaddition of nucleoside‐derived azido‐alkynes in a regio‐ and stereospecific manner. The thymine nucleoside base in these target compounds was transformed successfully into the corresponding 5‐methylcytosine component. The synthesized compounds were examined in a MAGI assay for exploring the anti‐HIV activity and in a H9 T lymphocytes assay for measuring the cell toxicity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 48 publications
0
3
0
Order By: Relevance
“…The synthesized compounds were tested for exploring the anti-HIV activity and in a H9 T lymphocytes assay for measuring the cell toxicity with modest results. 16 TSAO nucleoside analogues represent a class of HIV-1-specific agents, the prototype compound of which is the 1-[2',5'-bis-O-(tert-butyldimethylsilyl)--D-ribofuranosyl-thymine]-3'-spiro-5"-(4"-amino-1",2"-oxathiole-2",2"-dioxide (TSAO-T, 6). They are targeted at the HIV-1-encoded RT with which they interact at a nonsubstrate binding site; they are not antivirally effective against HIV-2 and other (retro)viruses.…”
Section: Nhmentioning
confidence: 99%
“…The synthesized compounds were tested for exploring the anti-HIV activity and in a H9 T lymphocytes assay for measuring the cell toxicity with modest results. 16 TSAO nucleoside analogues represent a class of HIV-1-specific agents, the prototype compound of which is the 1-[2',5'-bis-O-(tert-butyldimethylsilyl)--D-ribofuranosyl-thymine]-3'-spiro-5"-(4"-amino-1",2"-oxathiole-2",2"-dioxide (TSAO-T, 6). They are targeted at the HIV-1-encoded RT with which they interact at a nonsubstrate binding site; they are not antivirally effective against HIV-2 and other (retro)viruses.…”
Section: Nhmentioning
confidence: 99%
“…Thus, synthesis of cyclic dinucleotide analogues is a challenging yet exciting field of research and has the potential to revolutionize drug development. Wu and co‐workers reported the synthesis of triazolo‐fused 3’,5’‐cyclic nucleoside analogues I (Figure ) by an intramolecular 1,3‐dipolar cycloaddition of nucleoside‐derived azido‐alkynes . It was observed that these compounds exhibited anti‐HIV activity and cell toxicity.…”
Section: Introductionmentioning
confidence: 99%
“…The Huisgen 1,3‐dipolar cycloaddition between azide and alkyne leading to 1,5‐substitued triazole moiety has gained considerable attention due to its vast biological applications . Notably, several members of the 1,2,3‐triazole family have shown gripping biological properties, and the triazole moiety with its novel structural features and physiochemical properties is regarded as a privileged structure in drug design and discovery (Figure , 1–4 ) . When customized nucleosides possessing alkyne and azide moieties disposed in the same nucleosides are heated, they undergo intramolecular Huisgen cycloaddition to furnish 1,5‐disubstituted triazole compounds.…”
Section: Introductionmentioning
confidence: 99%